(Q43498496)

English

Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches

scientific article published on 11 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches (English)

1 reference

Europe PubMed Central

24 November 2017

5

1 reference

Europe PubMed Central

24 November 2017

author name string

Thomas Horn

1

1 reference

Europe PubMed Central

24 November 2017

Jessica Grab

2

1 reference

Europe PubMed Central

24 November 2017

Julia Schusdziarra

3

1 reference

Europe PubMed Central

24 November 2017

Sebastian Schmid

4

1 reference

Europe PubMed Central

24 November 2017

Roman Nawroth

6

1 reference

Europe PubMed Central

24 November 2017

Petra Wolf

7

1 reference

Europe PubMed Central

24 November 2017

Maria Pritsch

8

1 reference

Europe PubMed Central

24 November 2017

Jürgen E Gschwend

9

1 reference

Europe PubMed Central

24 November 2017

Hubert R Kübler

10

1 reference

Europe PubMed Central

24 November 2017

Philipp Beckhove

11

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

11 July 2013

1 reference

Europe PubMed Central

24 November 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

24 November 2017

133

1 reference

Europe PubMed Central

24 November 2017

2145-2156

1 reference

Europe PubMed Central

24 November 2017

9

1 reference

Europe PubMed Central

24 November 2017

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Detection of immune responses against urinary bladder cancer in sentinel lymph nodes.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Survivin expression is associated with bladder cancer presence, stage, progression, and mortality

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Response definition criteria for ELISPOT assays revisited

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Chronic pancreatitis is associated with disease-specific regulatory T-cell responses.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Immune parameters affecting the efficacy of chemotherapeutic regimens

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

The secret ally: immunostimulation by anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer-Specific Immune Responses and Their Correlation to Prognosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28233

21 January 2018

Identifiers

10.1002/IJC.28233

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43498496&oldid=1989931531"